diseases of upper gastrointestinal
Conditions
Interventions
Group A:Taking standard triple drug
Group B:Taking Saccharomyces boulardii scattered and standard triple drug
Sponsors
Daping Hospital, the Third Military Medical University, Chongqing, China
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. chronic gastritisor or duodenal ulcer patients without complicated; 2. rapid urease test was positive (>=2+) or 13C-breath test was positive before and after a week undergo endoscopy; 3. aged from 18 to 60,both male and female; 4. not received formal Hp eradication therapy before; 5. Signed informed consent.
Exclusion criteria
Exclusion criteria: 1. used antibiotics, bismuth, probiotics, H2 receptor antagonists and PPI 2 weeks before treatment; 2. pregnant or lactating women; 3. taking non-steroidal anti-inflammatory drugs or alcohol,or severe liver disease, heart disease, kidney disease, cancer and other diseases; 4. drug allergy patients; 5. gastrectomy patients; 6. 3 months prior to participating in other drug studies; 7. difficult to follow-up or to complete the various factors affecting.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hp eradication rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse reaction; | — |
Countries
China
Contacts
Public ContactLan ChunHui
Outcome results
None listed